Cat.#: ACPP-1169
| Despition | proBNP Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1473 | Human RAB5A Protein (AC1473) | 5 µg | inquiry |
| ACPP-1519 | Human MANF Protein (AC1519) | 5 µg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
| ACPP-1274 | Visfatin Blocking Peptide (AC1274) | 250 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.